B
Barbara Kofler
Researcher at Paracelsus Private Medical University of Salzburg
Publications - 172
Citations - 5618
Barbara Kofler is an academic researcher from Paracelsus Private Medical University of Salzburg. The author has contributed to research in topics: Galanin & Neuropeptide. The author has an hindex of 41, co-authored 154 publications receiving 4699 citations. Previous affiliations of Barbara Kofler include Garvan Institute of Medical Research & University of Innsbruck.
Papers
More filters
Journal ArticleDOI
The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease.
TL;DR: The wide range of functions of the galanin peptide family indicates an essential role for Galanin signaling in "mind and body homeostasis" and a potential therapeutic efficacy in a variety of human diseases, particularly epilepsy, Alzheimer's disease, and diabetes.
Journal ArticleDOI
Physiology, Signaling, and Pharmacology of Galanin Peptides and Receptors: Three Decades of Emerging Diversity
Roland Lang,Andrew L. Gundlach,Fiona E. Holmes,Sally A. Hobson,David Wynick,Tomas Hökfelt,Barbara Kofler +6 more
TL;DR: In this review, the importance of novel galanin receptor–specific agonists and antagonists are emphasized, and new approaches, including new transgenic mouse lines (such as a recently characterized GAL3 knockout mouse) represent, in combination with viral-based techniques, critical tools required to better evaluate Galanin system physiology.
Journal ArticleDOI
No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis
Katharina Bluemlein,Nana-Maria Grüning,René G. Feichtinger,Hans Lehrach,Barbara Kofler,Markus Ralser +5 more
TL;DR: The results reveal that an exchange in PKM1 to PKM2 isoform expression during cancer formation is not occurring, nor do these results support conclusions that PKM 2 is specific for proliferating, and PKM 1 for non-proliferating tissue.
Journal ArticleDOI
Ketogenic diet in the treatment of cancer - Where do we stand?
Daniela D. Weber,Sepideh Aminzadeh-Gohari,Julia Tulipan,Luca Catalano,René G. Feichtinger,Barbara Kofler +5 more
TL;DR: The ketogenic diet probably creates an unfavorable metabolic environment for cancer cells and thus can be regarded as a promising adjuvant as a patient-specific multifactorial therapy.
Journal ArticleDOI
The J-Bone Graft for Anatomical Glenoid Reconstruction in Recurrent Posttraumatic Anterior Shoulder Dislocation:
TL;DR: The J-bone graft is capable of creating a stable shoulder joint without causing extensive loss of motion on the long term in patients with traumatic glenoid rim fractures after shoulder dislocation.